Emily A. Blumberg
Experienced in Gonorrhea

Dr. Emily A. Blumberg

Infectious Disease | Transplant Surgery
University Of Penn-Medical Group
3400 Civic Ctr Blvd, 
Philadelphia, PA 
Offers Telehealth
39 Years of Experience
Experienced in Gonorrhea
University Of Penn-Medical Group
3400 Civic Ctr Blvd, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Emily Blumberg is an Infectious Disease specialist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Blumberg has been practicing medicine for over 39 years and is rated as an Experienced provider by MediFind in the treatment of Gonorrhea. Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, HIV/AIDS, Kidney Transplant, and Liver Transplant.

Her clinical research consists of co-authoring 165 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Infectious Disease
Transplant Surgery
Licenses
Internal Medicine in PA
Hospital Affiliations
Hospital Of Univ Of Pennsylvania
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AmeriHealth
  • EPO
  • HMO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care

Accepted plan types not found. Please verify directly with the provider.

Capital Blue Cross

Accepted plan types not found. Please verify directly with the provider.

Cigna
  • EPO
  • HMO
  • PPO
Clear Spring Health

Accepted plan types not found. Please verify directly with the provider.

Clover Health

Accepted plan types not found. Please verify directly with the provider.

Elixir

Accepted plan types not found. Please verify directly with the provider.

Geisinger Health System

Accepted plan types not found. Please verify directly with the provider.

Health Partners Plans

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independence
  • EPO
  • HMO
  • POS
  • PPO
Managed Medicaid

Accepted plan types not found. Please verify directly with the provider.

Medicaid

Accepted plan types not found. Please verify directly with the provider.

PA Health and Wellness

Accepted plan types not found. Please verify directly with the provider.

Silverscript

Accepted plan types not found. Please verify directly with the provider.

Tufts
  • HMO
UPMC
  • EPO
  • PPO
Vista360health

Accepted plan types not found. Please verify directly with the provider.

Walgreens

Accepted plan types not found. Please verify directly with the provider.

WellCare Health Plans

Accepted plan types not found. Please verify directly with the provider.

View 19 Less Insurance Carriers -

Locations

UNIVERSITY OF PENN-MEDICAL GROUP
3400 Civic Ctr Blvd, Philadelphia, PA 19104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

HOPE in Action Prospective Multicenter, Clinical Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
HOPE in Action Prospective Multicenter, Clinical Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
Enrollment Status: Active_not_recruiting
Publish Date: April 11, 2025
Intervention Type: Other
Study Phase: Not Applicable
A Randomized Study to Evaluate Antibody Response to an Additional Dose of SARS-CoV-2 Vaccination With and Without Immunosuppression Reduction in Kidney and Liver Transplant Recipients
A Randomized Study to Evaluate Antibody Response to an Additional Dose of SARS-CoV-2 Vaccination With and Without Immunosuppression Reduction in Kidney and Liver Transplant Recipients
Enrollment Status: Completed
Publish Date: April 10, 2025
Intervention Type: Drug, Biological
Study Phase: Phase 2
HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients
HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients
Enrollment Status: Completed
Publish Date: July 23, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis to Prevent COVID-19 in Immunocompromised Participants
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis to Prevent COVID-19 in Immunocompromised Participants
Enrollment Status: Terminated
Publish Date: July 24, 2023
Intervention Type: Drug
Study Drug: Casirivimab+Imdevimab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
A Phase 3, Multicenter, Randomized, Double-blind, Double-dummy, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Compared to Valganciclovir for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug, Other
Study Phase: Phase 3
Phase I Trial for the Prevention of Cytokine Release Syndrome (CRS) With Cyclosporine in Patients With Moderate COVID-19
Phase I Trial for the Prevention of Cytokine Release Syndrome (CRS) With Cyclosporine in Patients With Moderate COVID-19
Enrollment Status: Completed
Publish Date: January 11, 2022
Intervention Type: Drug
Study Drug: Cyclosporine
Study Phase: Phase 1
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Enrollment Status: Completed
Publish Date: February 02, 2021
Intervention Type: Drug
Study Phase: Phase 4
An International Prospective Observational Study to Assess the Characteristics and Outcomes of Post-transplant Patients Treatment for C. Difficile Infections
An International Prospective Observational Study to Assess the Characteristics and Outcomes of Post-transplant Patients Treatment for C. Difficile Infections
Enrollment Status: Completed
Publish Date: November 01, 2019
View 8 Less Clinical Trials

165 Total Publications

Letermovir use for cytomegalovirus prophylaxis following lung transplantation: A single-center review.
Letermovir use for cytomegalovirus prophylaxis following lung transplantation: A single-center review.
Journal: JHLT open
Published: March 27, 2025
Similar Doctors
Distinguished in Gonorrhea
Dr. Lenore E. Asbel
Infectious Disease
Distinguished in Gonorrhea
Dr. Lenore E. Asbel
Infectious Disease
219 N Broad St, 5th Floor, 
Philadelphia, PA 
 (1.7 mi)
215-762-6555
Languages Spoken:
English
See accepted insurances

Lenore Asbel is an Infectious Disease provider in Philadelphia, Pennsylvania. Dr. Asbel and is rated as an Advanced provider by MediFind in the treatment of Gonorrhea. Her top areas of expertise are Gonorrhea, Syphilis, Urethritis, and Chlamydia.

Advanced in Gonorrhea
Dr. Deborah D. Bayer
Infectious Disease | Palliative Medicine
Advanced in Gonorrhea
Dr. Deborah D. Bayer
Infectious Disease | Palliative Medicine
1401 Atlantic Ave, Suite 2200, 
Atlantic City, NJ 
 (57.3 mi)
609-441-2104
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Deborah Bayer is an Infectious Disease specialist and a Palliative Medicine provider in Atlantic City, New Jersey. Dr. Bayer and is rated as an Advanced provider by MediFind in the treatment of Gonorrhea. Her top areas of expertise are Myelitis, HIV/AIDS, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Bayer is currently accepting new patients.

Advanced in Gonorrhea
Dr. Deborah A. Kahal
Infectious Disease
Advanced in Gonorrhea
Dr. Deborah A. Kahal
Infectious Disease

Public Health Management Corporation

501 S 54th St, 
Philadelphia, PA 
 (2.0 mi)
215-731-2406
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Deborah Kahal is an Infectious Disease provider in Philadelphia, Pennsylvania. Dr. Kahal has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Gonorrhea. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Kahal is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Blumberg's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile